Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
LAST July, when Federal Reserve chair Janet Yellen spurred a sell-off in healthcare stocks by saying that valuations in shares of biotech companies looked "stretched", portfolio manager Graham Tanaka saw an opportunity.
After a year-long buying spree, he now has more than